HeartSciences regains Nasdaq minimum equity compliance; delisting risk cleared

HeartSciences Inc.

Received formal notice on Sept 16, 2025 that it regained compliance with Nasdaq Listing Rule 5550(b)(1) requiring minimum $2.5M stockholders' equity.
Previously disclosed non-compliance in March 2025; submitted a plan and received an extension from Nasdaq Staff.
The matter is now closed; no further action required regarding continued listing on Nasdaq Capital Market.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.